BLOOD LOSS ASSOCIATED WITH ADMINISTRATION OF LOW MOLECULAR WEIGHT DEXTRAN

[1] AGGELER PM, 1964, BLEEDING SURGICAL PA

[2] BAYLISS LE, 1962, HDB PHYSIOLOGY 2, V1, pCH8

[3] BERGENTZ SE, 1961, THROMB DIATH HAEMOST, V6, P15

[4] BRECKENRIDGE JM, 1963, LANCET, V1, P1190

[5] THE EFFECT OF CITRATE ON EUGLOBULIN METHODS OF ESTIMATING FIBRINOLYTIC ACTIVITY [J]. JOURNAL OF CLINICAL PATHOLOGY, 1958, 11 (05) : 403 - 405

[6] GELIN L E, 1961, Acta Chir Scand, V122, P287

[7] GELIN LARS-ERIK, 1961, ACTA CHIR SCAND, V122, P324

[8] GELIN LARS-ERIK, 1961, ACTA CHIR SCAND, V122, P294

[9] HAMILTON WF, 1962, HANDBOOK PHYSIOLOGY, V1, pCH8

[10] HEPPS SA, 1963, SURGERY, V54, P232

[1] AGGELER PM, 1964, BLEEDING SURGICAL PA

[2] BAYLISS LE, 1962, HDB PHYSIOLOGY 2, V1, pCH8

[3] BERGENTZ SE, 1961, THROMB DIATH HAEMOST, V6, P15

[4] BRECKENRIDGE JM, 1963, LANCET, V1, P1190

[5] THE EFFECT OF CITRATE ON EUGLOBULIN METHODS OF ESTIMATING FIBRINOLYTIC ACTIVITY [J]. JOURNAL OF CLINICAL PATHOLOGY, 1958, 11 (05) : 403 - 405

[6] GELIN L E, 1961, Acta Chir Scand, V122, P287

[7] GELIN LARS-ERIK, 1961, ACTA CHIR SCAND, V122, P324

[8] GELIN LARS-ERIK, 1961, ACTA CHIR SCAND, V122, P294

[9] HAMILTON WF, 1962, HANDBOOK PHYSIOLOGY, V1, pCH8

[10] HEPPS SA, 1963, SURGERY, V54, P232